FDA Clearance Tracker · P180028
HeartStart FRx Defibrillator
Last checked: Nov 20, 2026Latest source record: May 11, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 11, 2020
Approved
Time to decision
647 days
Received Aug 3, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180028
- Device name
- HeartStart FRx Defibrillator
- Applicant
- Philips Medical Systems
- Applicant location
- Bothell, WA
- Received
- Aug 3, 2018
- Decided
- May 11, 2020
- Decision
- Approved
- Supplements
- 19 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.5310
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the HeartStart FRx Defibrillator (Model 861304). The device is indicated for use on potential victims of sudden cardiac arrest (SCA) with the following symptoms:1) Unconsciousness; and2) Absence of normal breathingThe HeartStart FRx (Model 861304) is indicated for adults over 55 pounds (25 kg). The Model 861304 is also indicated for infants and children under 55 pounds (25 kg) or 0-8 years old when used with the optional Infant/Child Key (Model 989803139311). If the Infant/Child Key is not available, or you are uncertain of the childs age or weight, proceed using adult treatment without the infant/child key.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MKJ. The earliest in FDA's data is K853564, decided Oct 11, 1985.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Philips Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Zenition 30510(k)
K254205 · Decided Aug 7, 2026 · 221 days after receipt
Device type: Interventional Fluoroscopic X-Ray System (OWB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.